Comparison of Absorbed Dose Coefficients and Absorbed Doses for Several Compounds Labeled with 68Ga and 18F-FDG
| Target organ | Units | DOTATATE (Walker (21)) | DOTATOC (Hartmann (19)) | DOTANOC (Pettinato (18)) | DOTATOC (Sandstrom (20)) | DOTATATE (Sandstrom (20)) | HA-DOTATATE (Hartmann (22)) | 18F-FDG (ICRP 106 (23)) | Pentixafor (this work) |
| Kidneys | mSv/MBq | 9.21E–02 | 2.20E–01 | 8.97E–02 | 8.20E–02 | 9.30E–02 | 1.55E–01 | 1.70E–02 | 3.50E–02 |
| Liver | mSv/MBq | 4.50E–02 | 7.40E–02 | 3.38E–02 | 4.10E–02 | 5.00E–02 | 1.19E–01 | 2.10E–02 | 1.75E–02 |
| Spleen | mSv/MBq | 2.82E–01 | 2.40E–01 | 7.25E–02 | 1.08E–01 | 1.09E–01 | 2.62E–01 | 1.10E–02 | 5.38E–02 |
| Urinary bladder wall | mSv/MBq | 1.25E–01 | 7.00E–02 | 8.36E–02 | 1.19E–01 | 9.80E–02 | 3.84E–02 | 1.30E–01 | 8.14E–02 |
| Effective dose coefficient | mSv/MBq | 2.57E–02 | 2.30E–02 | 1.67E–02 | 2.10E–02 | 2.10E–02 | 2.45E–02 | 1.90E–02 | 1.56E–02 |
| Typical injected activity | MBq | 185 | 185 | 74 | 185 | 150 | 120 | 370 | 150 |
| Effective dose | mSv | 4.8 | 4.3 | 1.2 | 3.9 | 3.2 | 2.9 | 7.0 | 2.3 |